tryptophan and Cronkhite-Canada Syndrome

tryptophan has been researched along with Cronkhite-Canada Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bandyopadhyay, D; Damle, PK; Dcona, MM; Deng, X; Dennis, MJ; Ellis, KC; Escalante, C; Grossman, SR; Korwar, S; Morris, BL; Nawaz, Z; Royer, WE; Singh, SJ; Zarate-Perez, F	1

Other Studies

1 other study(ies) available for tryptophan and Cronkhite-Canada Syndrome

Article	Year
Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities. Molecular pharmacology, 2019, Volume: 96, Issue:1 Topics: Alcohol Oxidoreductases; Animals; Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Movement; Cell Survival; DNA-Binding Proteins; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hydroxylamines; Intestinal Polyposis; Mice; Mutagenesis, Site-Directed; Phenylpropionates; Protein Multimerization; Tryptophan; Xenograft Model Antitumor Assays	2019

Article

Year

Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

Molecular pharmacology, 2019, Volume: 96, Issue:1

Topics: Alcohol Oxidoreductases; Animals; Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Movement; Cell Survival; DNA-Binding Proteins; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hydroxylamines; Intestinal Polyposis; Mice; Mutagenesis, Site-Directed; Phenylpropionates; Protein Multimerization; Tryptophan; Xenograft Model Antitumor Assays

2019